Spectral AI Inc (NASDAQ:MDAI) announced it has added three new US trial sites to its 2024 Burn Pivotal Study, bringing the total number of sites, including burn centers and emergency departments, to 16.
The Medical Center Burn Center at Texas Tech University Health Sciences Center led by principal investigator Dr Alan Pang; Tampa General Hospital Burn Center led by principal investigator Dr Jared Troy; and the University of South Alabama Health Emergency Department led by Andrew Bright have been added to the study, the Dallas-based predictive AI company said on Tuesday.
Spectral AI’s study is designed to validate the AI-driven algorithm used by its DeepView System to provide clinicians with an objective assessment of the healing potential of a burn wound.
“The addition of these new sites brings us closer to completing the 2024 Burn Pivotal Study and seeking FDA approval for the DeepView System for burn indication in 2025,” Spectral AI CEO Peter Carlson said.
“We are grateful for the support of these esteemed clinicians and institutions in supporting our research and bringing true innovation to burn wound assessment and treatment.”
He added that the company expects the DeepView System to improve patient outcomes and reduce healthcare costs by providing faster and more accurate treatment insights.
“We believe that the potential of our AI-driven DeepView System to support the timely and accurate triage of a burn wound patient in a busy, sometimes chaotic, ED setting can deliver benefits across the healthcare ecosystem,” he said.
“Having an objective diagnostic tool can lead to immediate interventions that impact the treatment and outcome of burn wounds, while supporting improved institutional efficiencies.”